Resource Hub

Theranostics Adoption at PET Sites: A 2024–2026 Snapshot
Theranostics has long been synonymous with oncology — but IMV’s latest PET Census data suggests that association is starting to break down. A comparison of 2024 and 2026 survey findings reveals meaningful shifts in where theranostics procedures are being performed across PET sites, with implications for equipment planning, radiopharmaceutical demand, and clinical strategy.
See which care areas are driving theranostics growth — and which ones are emerging faster than expected
Why Download This Asset:
– See which care areas are driving theranostics growth — and which ones are emerging faster than expected
-Track how site-level adoption has changed from 2024 to 2026
– Understand where the market is heading as theranostics moves beyond its traditional stronghold
– Ground your strategy in census-level data from IMV’s trusted PET market research


